Prevalence of asymptomatic COVID positivity in the pre-operative patient
Not Applicable
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2021/04/032965
- Lead Sponsor
- Tata Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All patients who underwent preoperative SARS-C0V-2 testing prior to cancer surgery (elective and emergency)
Exclusion Criteria
symptomatic patients who planned to underwent preoperative SARS-C0V-2 testing prior to cancer surgery
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of asymptomatic infection among those patients undergoing routine preoperative testing before cancer surgery using RT-PCR of nasopharyngeal and oropharyngeal swabsTimepoint: 7 months
- Secondary Outcome Measures
Name Time Method -Intent and treatment received subsequently among those who tested positive. <br/ ><br>-Treatment completion rates, including adjuvant treatment. <br/ ><br>-Complication rates amongst patients who tested positive for SARS Cov2 infection <br/ ><br>-Proportion of patients who tested positive within 30 days after surgery after a negative preoperative test <br/ ><br>Timepoint: 7 months